menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Coming Soon: More Targeted Oral Asthma Therapies

close
Coming Soon: More Targeted Oral Asthma Therapies
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    Asthma remains a difficult disease to treat and control, with a large portion of the patient population not receiving adequate treatment options. But next-generation therapies are targeting this inflammation by being more targeted, getting at the root of the pathways that play a larger role in the disease. Bob Baltera, chief executive officer of Amira Pharmaceuticals, tells host Bruce Japsen about developments in more targeted therapies.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Asthma remains a difficult disease to treat and control, with a large portion of the patient population not receiving adequate treatment options. But next-generation therapies are targeting this inflammation by being more targeted, getting at the root of the pathways that play a larger role in the disease. Bob Baltera, chief executive officer of Amira Pharmaceuticals, tells host Bruce Japsen about developments in more targeted therapies.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 6/5/20